Register Login
Register to leave comments
  • News bot April 13, 2026, 10:06 a.m.

    📋 IDEAYA BIOSCIENCES, INC. (IDYA) - Clinical Trial Update

    Filing Date: 2026-04-13

    Accepted: 2026-04-13 06:05:15

    Event Type: Clinical Trial Update

    Event Details:

    IDEAYA BIOSCIENCES, INC. (IDYA) Announces Clinical Trial Update IDEAYA BIOSCIENCES, INC. (IDYA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Shoreline Court

    🔬 Clinical Development Pipeline (IDEAYA BIOSCIENCES, INC.):

    Product Type Development Stage Therapeutic Area Source
    Darovasertib DRUG Phase PHASE2 Uveal Melanoma ClinicalTrials.gov
    Nivolumab DRUG Phase PHASE2 Metastatic Uveal Melanoma ClinicalTrials.gov
    Crizotinib DRUG Phase PHASE1 Metastatic Uveal Melanoma ClinicalTrials.gov
    Primary Local Therapy PROCEDURE Phase PHASE3 Uveal Melanoma ClinicalTrials.gov
    Ipilimumab DRUG Phase PHASE2 Metastatic Uveal Melanoma ClinicalTrials.gov
    IDE034 DRUG Phase PHASE1 Esophageal Squamous Cell Carcinoma ClinicalTrials.gov
    IDE892 DRUG Phase PHASE1 NSCLC Adenocarcinoma ClinicalTrials.gov
    IDE161 DRUG Phase PHASE1 Small-cell Lung Cancer ClinicalTrials.gov
    durvalumab DRUG Phase PHASE1 Small-cell Lung Cancer ClinicalTrials.gov
    IDE849 DRUG Phase PHASE1 Small-cell Lung Cancer ClinicalTrials.gov
    PD-1 inhibitor BIOLOGICAL Phase PHASE1 Neoplasms, Colorectal ClinicalTrials.gov
    GSK4418959 DRUG Phase PHASE1 Neoplasms, Colorectal ClinicalTrials.gov
    Dacarbazine DRUG Phase PHASE2 Metastatic Uveal Melanoma ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE1 Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    IDE-161 DRUG Phase PHASE1 Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    Sacituzumab govitecan DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    IDE397 DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Binimetinib DRUG Phase PHASE1 Metastatic Uveal Melanoma ClinicalTrials.gov
    IDE196 DRUG Phase PHASE1 Metastatic Uveal Melanoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: IDEAYA BIOSCIENCES, INC.
    • Ticker Symbol: IDYA

Search

News categories